Identification
- Composition (DCI)
- oxaliplatine
- Manufacturer
- SUN PHARMACEUTICALS NORTH AFRICA S.A
- ATC code
- L01XA03
- Presentation
- Flacon de 10 ml
- Schedule / Reimb.
- A
- Hospital price
- 812.00 MAD
Indications
Traitement des cancers colorectaux métastatiques en combinaison avec 5-fluorouracile et acide folinique. Traitement adjuvant du cancer du côlon au stade III (stade C de Dukes) en combinaison avec 5-fluorouracile et acide folinique.
Find an open pharmacy
On-call pharmacies near you
About OXIPLAT 50 MG / 10 ML
OXIPLAT 50 MG / 10 ML is marketed in Morocco by SUN PHARMACEUTICALS NORTH AFRICA S.A and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of OXIPLAT 50 MG / 10 ML, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about OXIPLAT 50 MG / 10 ML
Answers to common questions from Moroccan patients about this drug.